MedKoo Cat#: 406312 | Name: AG-024104

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AG-024104 is a broad spectrum cyclin-​dependent kinase inhibitors with potential anticancer activity.

Chemical Structure

AG-024104
AG-024104
CAS#750575-23-6

Theoretical Analysis

MedKoo Cat#: 406312

Name: AG-024104

CAS#: 750575-23-6

Chemical Formula: C24H28F2N6O4S2

Exact Mass: 566.1582

Molecular Weight: 566.64

Elemental Analysis: C, 50.87; H, 4.98; F, 6.71; N, 14.83; O, 11.29; S, 11.32

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
AG024104; AG 024104; AG-024104
IUPAC/Chemical Name
(4-amino-2-((1-((6-(2-(dimethylamino)ethoxy)pyridin-3-yl)sulfonyl)piperidin-4-yl)amino)thiazol-5-yl)(2,6-difluorophenyl)methanone
InChi Key
OBHOHFUFLKWHSB-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H28F2N6O4S2/c1-31(2)12-13-36-19-7-6-16(14-28-19)38(34,35)32-10-8-15(9-11-32)29-24-30-23(27)22(37-24)21(33)20-17(25)4-3-5-18(20)26/h3-7,14-15H,8-13,27H2,1-2H3,(H,29,30)
SMILES Code
O=C(C1=C(N)N=C(NC2CCN(S(=O)(C3=CC=C(OCCN(C)C)N=C3)=O)CC2)S1)C4=C(F)C=CC=C4F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs
Storage Condition
0 – 4 oC for short term (weeks to 1 month) or -20 oC for long terms (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly.
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
        

Preparing Stock Solutions

The following data is based on the product molecular weight 566.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Jessen, Bart A.; Lee, Leo; Koudriakova, Tatiana; Haines, Morgan; Lundgren, Karen; Price, Sharon; Nonomiya, Jim; Lewis, Cristina; Stevens, Gregory J. Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitors. Journal of Applied Toxicology (2007), 27(2), 133-142 2. Chu, Shao Song; Alegria, Larry Andrew; Bleckman, Ted Michael; Chong, Wesley K. M.; Duvadie, Rohit K.; Li, Lin; Reich, Siegfried H.; Romines, William H.; Wallace, Michael B.; Yang, Yi. Preparation of thiazolylamino benzamide derivatives as modulators of cell proliferation and inhibitors of protein kinases. PCT Int. Appl. (2003), WO 2003004467 A2 20030116.